Medicine & Health, STEM, Research, Tufts University Antimicrobial Resistance and Development of Novel anti-Tuberculosis Therapies - Julia Silberman Developing Mycobacterium tuberculosis RecA Intein Inhibitors and Intein Splicing Inhibition Assay Andrew Singleton (he series) Jun 05, 2023 Share Tweet Share Share